Investigation of Non-Invasive Outcomes Predictors in Patients Undergoing DBS for Movement Disorders
1 other identifier
observational
21
1 country
1
Brief Summary
The purpose of the study is to determine if non-invasive measurements of brain waves from the skin called electroencephalography (EEG) can predict whether the brain stimulator will help your symptoms. Our goal is to obtain these brain wave measurements with patients both awake and under general anesthesia, and then to evaluate which brain wave patterns are associated with clinical improvement to determine if they could be useful for predicting whether the surgery will work. If such predictive measures were established based upon the findings of this study, they could be used in the future to improve surgical outcomes in the following ways: (1) to help guide surgical targeting in the operating room awake or under anesthesia, (2) to guide post-operative programming in clinic, and (3) and to develop potential feedback systems for "automatic" programming of the brain stimulator system at home.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 29, 2015
CompletedFirst Posted
Study publicly available on registry
July 2, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedMay 11, 2018
May 1, 2018
2.5 years
June 29, 2015
May 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
Validated rating scale for measuring symptoms of Parkinson's disease
Change in the rating scale score at 6 months post-op versus pre-op baseline
The Essential Tremor Rating Assessment Scale (TETRAS)
Validated rating scale for measuring symptoms of essential tremor
Change in the rating scale score at 6 months post-op versus pre-op baseline
Burke-Fahn-Marsden (BFM) Dystonia Rating Scale
Validated rating scale for measuring symptoms of primary dystonia
Change in the rating scale score at 6 months post-op versus pre-op baseline
Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS)
Validated rating scale for measuring symptoms of primary cervical/segmental dystonia
Change in the rating scale score at 6 months post-op versus pre-op baseline
Yale Global Tic Severity Scale
Validated rating scale for tic severity
Change in the rating scale score at 6 months post-op versus pre-op baseline
Deep Brain Stimulation (DBS) Therapeutic Window
Measurement of the available range of stimulation intensities for therapy for each contact on the DBS electrode array
1 month post-operative scores for each contact on the DBS electrode array
Study Arms (1)
DBS subjects
deep brain stimulation (DBS) in patients with Parkinson's disease, tremor, dystonia, and Tourette's syndrome
Eligibility Criteria
Patients who undergo deep brain stimulation as part of routine clinical care for movement disorders (Parkinson's disease, essential tremor, dystonia, Tourette's syndrome).
You may qualify if:
- Patients who elect to undergo deep brain stimulation as part of routine clinical care for movement disorders (Parkinson's disease, essential tremor, dystonia, Tourette's syndrome).
- Adults, ages 19 and older
You may not qualify if:
- Patients who are unable to consent to the research for cognitive or behavioral reasons
- Patients who are medically too ill to participate, and
- Patients who have their DBS programming at outside facilities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Alabama at Birminghamlead
- Medtroniccollaborator
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Harrison Walker, MD
University of Alabama at Birmingham
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Neurology
Study Record Dates
First Submitted
June 29, 2015
First Posted
July 2, 2015
Study Start
June 1, 2014
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
May 11, 2018
Record last verified: 2018-05